Nearly two-thirds of industry experts ranked IQVIA as the leader among decentralized trial solutions – more than any other technology or service provider.1 Our tested DCT model leverages technology and specialized services to engage participants within the community, and facilitate patient centric care including pre-screening, telemedicine visits, at-home treatment, or mobile research nurses and staff services.
Built on a foundation of global clinical operations capabilities and privacy compliance expertise, IQVIA Decentralized Trials is the first service provider to receive GDPR compliance validation from TRUSTArc, marking the first instance of a DCT service receiving this European data privacy validation.2
1Industry Standard Research, 2021
2IQVIA Decentralized Clinical Trial Program Achieves Independent GDPR Validation, 2022
and over 30 indications using IQVIA Decentralized Trials
Successful patient retention in these studies means treating the caregivers as key stakeholders in the clinical trial journey, starting at recruitment.
An update on progress and results
IQVIA, ACRO and SCRS leaders share best practices for improving the cost and quality of DCTs.
New study proves that choosing decentralized clinical trials enables reduced time and cost, delivering measurable benefits for sponsors.
Q&A with industry experts from IQVIA and the University of Michigan explore the challenges sites currently face and what sponsors can do to ease the transition.
Tackling 5 common myths about their roles within clinical trials
IQVIA Decentralized Trials Platform helps sponsors deploy adaptable, patient-centric DCT technology for trials of all sizes, customized to fit any study and any indication – anywhere on the globe.
Available in dozens of languages, our end-to-end DCT platform expands traditional site boundaries to deliver a more efficient, more personalized experience without compromising the precision and rigor of the trial.
IQVIA’s DCT platform empowers patients across the globe with a concierge digital experience, including: text reminders, alerts, live chat, 24/7 support, and a scheduling tool to confirm or reschedule study visits.
Clinical trials face increasing pressure to deliver new treatments to market faster. IQVIA Connected Devices accelerates trial outcomes with medical device recommendations that fit your clinical study, deliver cleaner data, and speed data collection and analysis with lower patient and site burdens.
Technology informed by unparalleled Decentralized Trials (DCT) operational experience and delivered at global scale.
Predict enrollment more accurately and increase the number of patients per site using data-driven patient recruitment solutions.
Enhance patient safety and study quality by using data, analytics, and technology to monitor patient, site, and study performance with risk-based and centralized monitoring.
.svg){kind=icon}
